metoprolol has been researched along with Hypertension, Pulmonary in 5 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Nebivolol was more potent than metoprolol in improving cardiac function, pulmonary vascular remodeling, and inflammation of rats with monocrotaline-induced pulmonary hypertension." | 3.81 | Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. ( Antigny, F; Bentebbal, S; Bogaard, HJ; Dorfmüller, P; Eddahibi, S; Fadel, E; Happé, C; Humbert, M; Izikki, M; Jourdon, P; Lecerf, F; Perros, F; Ranchoux, B; Simonneau, G, 2015) |
| "Metoprolol treatment did not delay the onset of heart failure symptoms, improve mitochondrial function, or regress RV hypertrophy." | 1.51 | Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment. ( Hickey, AJ; Jones, TLM; Norman, R; Power, AS; Ward, ML, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Power, AS | 1 |
| Norman, R | 1 |
| Jones, TLM | 1 |
| Hickey, AJ | 1 |
| Ward, ML | 1 |
| Perros, F | 1 |
| Ranchoux, B | 1 |
| Izikki, M | 1 |
| Bentebbal, S | 1 |
| Happé, C | 1 |
| Antigny, F | 1 |
| Jourdon, P | 1 |
| Dorfmüller, P | 1 |
| Lecerf, F | 1 |
| Fadel, E | 1 |
| Simonneau, G | 1 |
| Humbert, M | 1 |
| Bogaard, HJ | 1 |
| Eddahibi, S | 1 |
| Dmuchowska, DA | 1 |
| Zalewska, R | 1 |
| Jasiewicz, M | 1 |
| Krasnicki, P | 1 |
| Mikita, A | 1 |
| Sobkowicz, B | 1 |
| Mariak, Z | 1 |
| Sarraf, D | 1 |
| Peacock, A | 1 |
| Ross, K | 1 |
| Crilley, JG | 1 |
| Dark, JH | 1 |
| Hall, JA | 1 |
5 other studies available for metoprolol and Hypertension, Pulmonary
| Article | Year |
|---|---|
Mitochondrial function remains impaired in the hypertrophied right ventricle of pulmonary hypertensive rats following short duration metoprolol treatment.
Topics: Adenosine Triphosphatases; Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Animals; Di | 2019 |
Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Benzopyrans; Cell Communication; Cell Culture Techn | 2015 |
Diagnostic and Therapeutic Challenges.
Topics: Amlodipine; Antihypertensive Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Hum | 2015 |
Pulmonary hypertension: a contraindication to the use of {beta}-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Contraindications; Female; Heart Arrest; Humans; Hypertension, Pulmonar | 2010 |
Reversal of severe pulmonary hypertension with beta blockade in a patient with end stage left ventricular failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Cardiac Output; Dobutamine; Drug A | 1998 |